VCYT
$43.12-2.86%
Veracyte Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.010%US Stock Market 0.006%Russell 3000 0.006%
Veracyte Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Veracyte Inc. total returns by year (2014–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $42.10 | $43.12 | 0.0% | +2.4% | |
| 2025 | $39.60 | $42.10 | 0.0% | +6.3% | |
| 2024 | $27.51 | $39.60 | 0.0% | +43.9% | |
| 2023 | $23.73 | $27.51 | 0.0% | +15.9% | |
| 2022 | $41.20 | $23.73 | 0.0% | -42.4% | |
| 2021 | $48.94 | $41.20 | 0.0% | -15.8% | |
| 2020 | $27.92 | $48.94 | 0.0% | +75.3% | |
| 2019 | $12.58 | $27.92 | 0.0% | +121.9% | |
| 2018 | $6.53 | $12.58 | 0.0% | +92.6% | |
| 2017 | $7.74 | $6.53 | 0.0% | -15.6% | |
| 2016 | $7.20 | $7.74 | 0.0% | +7.5% | |
| 2015 | $9.66 | $7.20 | 0.0% | -25.5% | |
| 2014 | $14.50 | $9.66 | 0.0% | -33.4% |
- Annualized
- +10.1%
- 2014–2026
- Average year
- +19.2%
- 12 full years
- Best year
- +121.9%
- 2019
- Worst year
- -42.4%
- 2022
- Positive years
- 7/12
- 58% up
Annualized (CAGR)
+10.1%
2014–2026
Average year
+19.2%
12 full years
Best year
+121.9%
2019
Worst year
-42.4%
2022
Positive years
7/12
58% up
Total return by period#
Annual
-100%-50%0%50%100%
2014-33%'14
2015-25%'15
2016+7.5%'16
2017-16%'17
2018+93%'18
2019+122%'19
2020+75%'20
2021-16%'21
2022-42%'22
2023+16%'23
2024+44%'24
2025+6.3%'25
2026+2.4%'26
Methodology#
Total returns, dividends reinvested, measured on VCYT. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Veracyte Inc.'s average annual return?
- Since 2014, Veracyte Inc. (VCYT) has returned about 10.1% a year (the compound annual growth rate) and an average calendar-year return of 19.2%.
- What were Veracyte Inc.'s best and worst years?
- Over 2014–2026, the best year was 2019 (+121.9%) and the worst was 2022 (-42.4%).
- How often is Veracyte Inc. up in a year?
- 7 of the 12 full years since 2014 were positive — about 58% of the time.
More on Veracyte Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100